The Food and Drug Administration on Tuesday approved Rempex Pharmaceuticals' antibacterial drug Vabomere.
Here are three things to know.
- The drug is approved to treat adults with complicated urinary tract infections, including a type of kidney infection called pyelonephritis.
- Vabomere is an intravenous combination drug made up of meropenem — an antibiotic — and vaborbactam, which inhibits certain resistance mechanisms used by bacteria.
- Rempex Pharmaceuticals' expects Vabomere to hit the market in the fourth quarter of this year.